Piperine enhances doxorubicine sensitivity in triple negative breast cancer cell lines by down-regulating PI3K/AKT/mTOR signaling pathways and suppressed ALDH1 expression [245]. This evidence concerns the gene ALDH1A1 and triple-negative breast carcinoma.